Could Gelteq’s (GELS) Gel Improve Oral Drug Delivery?
Gelteq (GELS) is advancing its gel-based oral drug delivery technology, having produced a commercial product for an East Asian client and opened a Center of Excellence in China. The company secured $3.5M in debt financing to support commercialization and clinical programs. Key milestones include clinical trials, regulatory progress, and securing new customer orders. Investors are watching to see if the technology can become a repeatable platform across various products and markets.

